DRAFT: This module has unpublished changes.

Joner, M., Finn, A. V., Farb, A., Mont, E. K., Koplodgie, F. D., Ladich, E., . .
     . Virmani, R. (n.d.). Pathology of Drug-Eluting Stents in Humans: Delayed
     Healing and Late Thrombotic Risk.
       This study examined drug eluting stents in Human Clinical trials in
       order to determine the long term results of DES implantations on arterial
       healing and the development of late stage thrombosis. Comparing the
       windows of Thrombotic risk in both Drug eluting and bare metal stents, it
       is seen that drug eluting stents represent a longer risk for the
       development of arterial complications. Concluding that DES inhibit
       arterial healing as compared to bare metal stents, which allow faster
       recovery while increasing risk of restinosis, this study further defined
       the problems associated with DES in today's medical field.

DRAFT: This module has unpublished changes.